Body Protection Compound-157 (BPC-157) is a synthetic peptide derived from a protein found in human gastric juice. Over the past two decades, researchers have accumulated compelling evidence that this 15-amino acid peptide exerts remarkable effects on tissue healing across multiple organ systems.
What Is BPC-157?
BPC-157 is a partial sequence of the body protection compound (BPC) that is found in human gastric juice. The peptide was first identified in the 1990s and has since become one of the most studied compounds in regenerative peptide research. Its full sequence is Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val.
Mechanisms of Action
BPC-157 appears to operate through several distinct pathways that collectively promote tissue repair and reduce inflammation:
- Angiogenesis promotion: Research suggests BPC-157 upregulates VEGF expression, supporting new blood vessel formation critical to tissue healing.
- Growth hormone receptor modulation: Studies indicate the peptide may sensitize tissue to growth hormone signaling, amplifying regenerative responses.
- Nitric oxide pathway: BPC-157 appears to modulate the NO-system, which plays a key role in vascular tone and inflammation regulation.
- Tendon and ligament fibroblast activation: In vitro studies show significantly accelerated fibroblast migration and proliferation in tendons exposed to BPC-157.
Research Findings by Tissue Type
Gastrointestinal Tract
As a gastric peptide, BPC-157 has shown particular efficacy in studies of GI tissue. Animal models demonstrate accelerated healing of gastric ulcers, reduced inflammatory bowel disease markers, and protection against NSAID-induced GI damage. Researchers have documented effects across the entire GI tract from esophagus to colon.
Musculoskeletal Tissue
Some of the most robust BPC-157 research involves tendon and ligament healing. Multiple controlled animal studies have shown significantly faster healing of surgically severed Achilles tendons in BPC-157-treated groups compared to controls. Similar results have been observed in medial collateral ligament transection models.
Bone and Cartilage
Emerging research suggests BPC-157 may accelerate bone fracture healing and could have protective effects on cartilage. Studies using tibial fracture models show improved callus formation and earlier return of structural integrity.
Neural Tissue
A growing body of research explores BPC-157’s potential neuroprotective properties, including effects on dopaminergic and serotonergic systems, and possible benefits in models of traumatic brain injury.
Research Considerations
It is important to note that the overwhelming majority of BPC-157 research has been conducted in rodent models. While these findings are encouraging and mechanistically plausible, controlled human clinical trials are limited.
BPC-157 is currently classified as a research compound. It is not approved by the FDA for any medical use and is intended solely for laboratory research purposes.
This article is for informational and research purposes only. BioSource Peptides products are sold exclusively for laboratory research. Not for human consumption.